Form 8.3 – [MARLOWE PLC – 12 06 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Form 8.3 – [ALPHA GROUP INTERNATIONAL PLC – 12 06 2025]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
180 Degree Capital Corp. Notes Filing of Updated Preliminary Joint Proxy Statement/Prospectus for Proposed Business Combination With Mount Logan Capital Inc.
MONTCLAIR, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) (“180 Degree Capital”) today noted the filing of an amended preliminary joint proxy statement/prospectus on Schedule 14A…
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchit’s Concurrent Financing
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- 1317229 B.C. Ltd. (“131” or the “Company”) and Launchit Solutions Inc. (“Launchit”) are pleased to announce that the Company, Launchit and…
Dimensional Fund Advisors Ltd. : Form 8.3 – RICARDO PLC
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.KEY INFORMATION (a)Full name of discloser:Dimensional Fund Advisors…
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy Acquisition of CureVac will…
BioNTech kündigt strategische Transaktion zur Übernahme von CureVac im Rahmen eines öffentlichen Umtauschangebots an
Die geplante Übernahme soll die Forschung, Entwicklung, Herstellung und Kommerzialisierung von mRNA-basierten Krebsimmuntherapie-Kandidaten stärken und ist ein weiterer wichtiger Meilenstein in der Umsetzung von BioNTechs Onkologie-StrategieDie Übernahme von CureVac ergänzt…
FORVIA FURTHER IMPROVES ITS DEBT PROFILE BY USING PROCEEDS FROM AN ADDITIONAL ISSUANCE OF SENIOR NOTES DUE 2030 AND AVAILABLE CASH TO REPURCHASE EXISTING 2027 SUSTAINABILITY-LINKED NOTES
Not for distribution, directly or indirectly, in the United States, Canada, Australia or Japan. NANTERRE (FRANCE)JUNE 11, 2025 FORVIA FURTHER IMPROVES ITS DEBT PROFILE BY USING PROCEEDS FROM AN ADDITIONAL…
Methanex Corporation Receives Regulatory Approval for the Acquisition of OCI Global’s Methanol Business
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Methanex Corporation (TSX:MX) (Nasdaq:MEOH) announced today that the regulatory review period under the U.S. Hart-Scott-Rodino Antitrust Act has lapsed. Accordingly, all…
Lancaster Resources Inc. Expands Exploration in Quebec’s James Bay with Lac Iris Polymetallic Project Acquisition
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF) (“Lancaster”), is pleased to announce the acquisition of a 100% interest in the Lac…